Opportunity Information: Apply for CDC RFA DD 26 0222
The Centers for Disease Control and Prevention (CDC), through the National Center on Birth Defects and Developmental Disabilities (NCBDDD), is offering a cooperative agreement funding opportunity called "Long-term health outcomes of people living with spina bifida" (Funding Opportunity Number: CDC RFA DD 26 0222; CFDA 93.073). The overall focus is on strengthening and using long-term, real-world clinical data to better understand how children and adults with spina bifida (SB) are doing over time, particularly after different interventions and treatments, and then using that evidence to improve care. The work is grounded in specialty spina bifida clinics that already participate in the National Spina Bifida Patient Registry (NSBPR), meaning the program is designed to build on an existing national infrastructure rather than starting from scratch.
The opportunity is split into two components with related but distinct goals. Component A is designed for approximately 8 to 11 awardees and centers on high-quality longitudinal data collection. In practical terms, this means participating clinics will continue tracking patients with SB across time, capturing standardized information that can show changes in health status, functional outcomes, complications, and other meaningful measures as patients age from childhood into adulthood. The point is not only to gather data, but to ensure it is consistent, complete, and reliable enough to support strong analyses. By sustaining and improving this ongoing data stream, Component A supports a clearer picture of long-term outcomes and variation in care and results across clinical settings.
Component B is intended for approximately 6 to 8 awardees and goes beyond data collection into active clinical quality improvement focused on urologic and kidney health in young children. Specifically, Component B sites will implement and evaluate the UMPIRE iterative protocol (Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida). UMPIRE targets infants and young children with myelomeningocele, a severe form of spina bifida, with the goal of improving urinary tract and kidney management early in life to help preserve renal function. In addition to implementing UMPIRE and studying how well it works in real clinic environments, a key objective is to finalize the UMPIRE protocol for children ages 0 to 10 with myelomeningocele. That implies the protocol is expected to be refined based on what is learned during implementation, including feasibility, adherence, outcomes, and potentially how the protocol performs across different clinical contexts.
Across both components, recipients are expected to do more than simply submit data. The NOFO emphasizes analyzing the collected information and sharing findings to identify opportunities to improve care. This creates a feedback loop: clinics contribute longitudinal registry data, the data are analyzed to understand outcomes and the impact of interventions, and the lessons learned are communicated in ways that can improve clinical practice. Because the funding instrument is a cooperative agreement, applicants should expect meaningful involvement from CDC (for example, coordination, guidance, standardization efforts, and collaborative evaluation), rather than a hands-off grant structure.
From an administrative standpoint, the opportunity is categorized as discretionary funding in the health activity category, with an award ceiling of $300,000 and an expected total of 19 awards across both components. The original closing date is 2026-10-26, and the opportunity was created on 2026-08-26. Eligibility is broad and includes multiple levels of government (state, county, city/township, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (including entities other than small businesses), and small businesses. In effect, the program is open to a wide range of organizational types, but the core operational requirement implied by the description is access to or partnership with specialized spina bifida clinics that can contribute high-quality clinical registry data and, for Component B, carry out protocol-based urologic management and evaluation in young children.
In summary, this NOFO supports a national effort to improve understanding and management of spina bifida by sustaining robust longitudinal surveillance through the NSBPR (Component A) and by actively testing and refining a structured urologic management approach intended to protect kidney health in early childhood (Component B). The intended result is stronger evidence about long-term outcomes, clearer insight into what interventions work best for which patients, and practical improvements in the quality and consistency of care delivered in specialty spina bifida clinics.Apply for CDC RFA DD 26 0222
- The Centers for Disease Control - NCBDDD in the health sector is offering a public funding opportunity titled "Long-term health outcomes of people living with spina bifida" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.073.
- This funding opportunity was created on 2026-08-26.
- Applicants must submit their applications by 2026-10-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 19 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The cooperative agreement funding opportunity is titled "Long-term health outcomes of people living with spina bifida."
Who is offering this opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC) through the National Center on Birth Defects and Developmental Disabilities (NCBDDD).
What is the Funding Opportunity Number (FONO) and CFDA number?
The Funding Opportunity Number is CDC RFA DD 26 0222 and the CFDA number is 93.073.
What is the main goal of this program?
The overall goal is to strengthen and use long-term, real-world clinical data to better understand how children and adults living with spina bifida are doing over time, including after different interventions and treatments, and to use that evidence to improve care.
What kind of funding mechanism is being used?
This opportunity uses a cooperative agreement. That means CDC is expected to have meaningful involvement (such as coordination, guidance, standardization efforts, and collaborative evaluation) rather than operating as a hands-off funder.
Is this program starting a new data system from scratch?
No. The work is grounded in specialty spina bifida clinics that already participate in the National Spina Bifida Patient Registry (NSBPR), so it is designed to build on an existing national infrastructure.
How is the opportunity structured?
The opportunity is split into two components with related but distinct goals: Component A (longitudinal data collection) and Component B (clinical quality improvement focused on urologic and kidney health in young children).
What is Component A focused on?
Component A focuses on high-quality longitudinal data collection through participating clinics. This includes continuing to track patients with spina bifida over time using standardized information that can show changes in health status, functional outcomes, complications, and other meaningful measures as patients age from childhood into adulthood.
How many awards are expected under Component A?
Approximately 8 to 11 awardees are expected for Component A.
What is the practical purpose of Component A data collection?
The intent is not only to gather data, but to ensure it is consistent, complete, and reliable enough to support strong analyses. This supports a clearer picture of long-term outcomes and variation in care and results across clinical settings.
What is Component B focused on?
Component B goes beyond data collection into active clinical quality improvement centered on urologic and kidney health in young children. Component B sites will implement and evaluate the UMPIRE iterative protocol.
How many awards are expected under Component B?
Approximately 6 to 8 awardees are expected for Component B.
What is UMPIRE?
UMPIRE stands for Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida. It is an iterative protocol intended to improve early urinary tract and kidney management to help preserve renal function.
Which children are specifically targeted by UMPIRE in this opportunity?
UMPIRE targets infants and young children with myelomeningocele, a severe form of spina bifida.
What age range is mentioned for finalizing the UMPIRE protocol?
A key objective is to finalize the UMPIRE protocol for children ages 0 to 10 with myelomeningocele.
What does it mean that UMPIRE is an "iterative protocol" in this program?
It implies the protocol is expected to be refined based on what is learned during real-world implementation, including feasibility, adherence, outcomes, and how the protocol performs across different clinical contexts.
Beyond submitting data, what are recipients expected to do?
Recipients are expected to analyze collected information and share findings to identify opportunities to improve care. The program emphasizes a feedback loop where clinics contribute data, analyses are conducted to understand outcomes and the impact of interventions, and lessons learned are communicated in ways that can improve clinical practice.
What clinical setting is central to this program?
Specialty spina bifida clinics that already participate in the NSBPR are central, since the program relies on high-quality clinical registry data and, for Component B, protocol-based urologic management and evaluation in young children.
How many total awards are expected across both components?
The opportunity expects a total of 19 awards across both components.
What is the award ceiling?
The award ceiling is $300,000.
How is the opportunity categorized?
It is categorized as discretionary funding in the health activity category.
What are the key dates for this opportunity?
The opportunity was created on 2026-08-26, and the original closing date is 2026-10-26.
What types of organizations are eligible to apply?
Eligibility includes state, county, and city/township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; nonprofits (both 501(c)(3) and non-501(c)(3)); for-profit organizations (including entities other than small businesses); and small businesses.
Does eligibility require being a specialty spina bifida clinic?
The eligibility list is broad, but the description implies a core operational need: access to or partnership with specialized spina bifida clinics that can contribute high-quality NSBPR-based clinical registry data and, for Component B, carry out UMPIRE protocol implementation and evaluation in young children.
What outcomes is the program ultimately trying to improve or understand?
The program aims to produce stronger evidence about long-term outcomes for people living with spina bifida, better understand the impact of interventions and treatments, and drive practical improvements in the quality and consistency of care, including protecting kidney health through improved early urologic management in young children.
Browse more opportunities from the same category: Health
Previous opportunity: Early Warning and Response in Nigeria
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD 26 0222
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD 26 0222) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) Apply for RFA AI 27 005 Funding Number: RFA AI 27 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) Apply for PAR 27 076 Funding Number: PAR 27 076 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) Apply for RFA DK 27 112 Funding Number: RFA DK 27 112 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 27 053 Funding Number: PAR 27 053 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) Apply for RFA AI 27 014 Funding Number: RFA AI 27 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Trauma Care Readiness and Coordination Cooperative Agreement Apply for EP U3R 26 002 Funding Number: EP U3R 26 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $500,000 |
| Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats Apply for RD ET RDA 26 002 Funding Number: RD ET RDA 26 002 Agency: Office of National Drug Control Policy Category: Health Funding Amount: $300,000 |
| Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations Apply for CDC RFA DP 27 0023 Funding Number: CDC RFA DP 27 0023 Agency: Centers for Disease Control - NCCDPHP Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD 26 0222", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
